Tsyganova I V, Anurova O A, Mazurenko N N
Arkh Patol. 2011 Nov-Dec;73(6):37-42.
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the gastrointestinal tract. Analysis of GIST morphology is necessary for selection of primary patients with the high risk of tumor progression for adjuvant treatment with gleevek following complete gross resection of KIT (CD 117)-positive GIST. In this study we've analyzed morphological parameters and survival of 120 GIST patients before target therapy. According to risk stratification of primary GIST by tumor location, size and mitotic index (mitoses per 50 visual fields) 44% of gastric GISTs, 87,5% of small bowel GISTs and 100% of rectum GISTs have been classified as high risk group. There was no significant difference between survival of patients with different type of GIST, Ki-67 proliferative index and presence of necrosis.
胃肠道间质瘤(GIST)是胃肠道最常见的间叶性肿瘤。对GIST形态进行分析,对于选择肿瘤进展风险高的初治患者在完全肉眼切除KIT(CD 117)阳性GIST后接受格列卫辅助治疗很有必要。在本研究中,我们分析了120例GIST患者在接受靶向治疗前的形态学参数和生存情况。根据肿瘤位置、大小和有丝分裂指数(每50个视野中的有丝分裂数)对原发性GIST进行风险分层,44%的胃GIST、87.5%的小肠GIST和100%的直肠GIST被归类为高风险组。不同类型GIST患者的生存情况、Ki-67增殖指数和坏死情况之间无显著差异。